Xintela AB Market Cap

Xintela AB has a market cap or net worth of 212.73 million as of April 28, 2026. Its market cap has decreased by -9.74% in one year.

Market Cap

212.73M

Enterprise Value

189.52M

Revenue

2.28M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.25

Market Cap Chart

Since March 22, 2016, Xintela AB's market cap has increased from 103.68M to 212.73M, an increase of 105.18%. That is a compound annual growth rate of 7.37%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	228.24M	14.88%
Dec 30, 2025	198.68M	5.85%
Dec 30, 2024	187.69M	26.87%
Dec 29, 2023	147.94M	-1.74%
Dec 30, 2022	150.56M	-26.24%
Dec 30, 2021	204.12M	2.23%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Isofol Medical AB	222.74M
Initiator Pharma	214.26M
Xbrane Biopharma AB	196.16M
Mendus AB	300.61M
Sprint Bioscience AB	311.27M
Bio-Works Technologies AB	317.16M
Active Biotech AB	175.03M
Diamyd Medical AB	165.83M

Market Cap Rankings